Background. We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHIF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities.
Background. We have shown previously that norepinephrine (NE) uptake activity is reduced in the failing right ventricle of animals with right heart failure (RHF) produced by tricuspid avulsion and progressive pulmonary constriction. However, it is unknown whether this defect in neuronal NE uptake is related to reduction of noradrenergic nerve terminals or whether these changes also occur in animals with left heart failure (LHIF). It is also unknown whether increased NE release in heart failure contributes to the noradrenergic nerve abnormalities.
Methods and Results. We measured myocardial NE content, NE uptake function, and noradrenergic nerve profiles in dogs with either RHF or LHF induced by rapid ventricular pacing. NE uptake activity was measured using [HINE, and noradrenergic nerve profiles were visualized by glyoxylic acid (SPG)-induced histofluorescence and tyrosine hydroxylase immunocytochemical staining. To study the effects of excess NE, we exposed normal dogs to 8 weeks of chronic NE infusion using subcutaneous osmotic minipumps. RHF and LHF animals exhibited reduced myocardial contractile function and congestive heart failure, as evidenced by reduced cardiac output and elevated right atrial pressure. However, unlike that in LHF, left atrial pressure was not increased in RHF. The animals also showed an increase in plasma NE and a decrease in cardiac NE. In addition, SPG-induced histofluorescence correlated significantly with NE uptake activity (r=.712, P<.001) and tyrosine hydroxylase immunoreactive profiles (r=.569, P<.001) in the right ventricles of RHF dogs and in both ventricles of LHF dogs. The numbers of catecholaminergic profiles and tyrosine hydroxylase profiles significantly correlated with cardiac filling pressures. Chronic infusion of NE decreased heart rate in normal dogs but had no effect on either mean aortic pressure or left atrial pressure; like heart failure, it resulted in significant decreases in myocardial NE uptake activity and numbers of SPG-induced catecholaminergic histofluorescence and immunoreactive tyrosine hydroxylase profiles.
Conclusions. Myocardial NE uptake activity was reduced only in the failing ventricles with elevated filling pressure in RHF and LHF. These changes probably were caused by loss of noradrenergic nerve terminals in the failing ventricles, as evidenced by the reductions of catecholaminergic histofluorescence and tyrosine hydroxylase immunostained profiles. Furthermore, since similar reductions of myocardial NE uptake and noradrenergic nerve profiles could be produced by chronic NE infusion in normal dogs, elevated NE levels may play a role in the development of cardiac noradrenergic nerve abnormalities in congestive heart failure. (Circulation. 1993; 88:1299 -1309 KEY WoRDs * congestive heart failure * sympathetic nerves * catecholamines * tyrosine hydroxylase * norepinephrine W e have shown in dogs with right heart failure (RHF) produced by progressive pulmonary constriction and tricuspid avulsion that myocardial 13-adrenoceptor 12 The surgical procedures that entailed staged right and left thoracotomies for anterior tricuspid valve avulsion, placement of a silicone rubber balloon occluder around the pulmonary artery, and insertion of indwelling catheters in the right atrium, main pulmonary artery, left atrium, and aorta, and a Konigsberg micromanometer (Konigsberg Instruments, Pasadena, Calif) in the left ventricle were described previously.12 Two weeks later, the balloon occluder was inflated progressively to constrict the pulmonary artery at 4-to 7- After the hemodynamic studies, the animal was given a lethal dose (>100 mg/kg) of sodium pentobarbital. The heart, lungs, and liver were removed and weighed. The ventricles were separated from the septum and rinsed in an ice-cold oxygenated normal saline. The left ventricular weight included both the septum and left ventricular free wall; the right ventricular weight included only the free wall. Ventricular muscle blocks were removed quickly from ventricular free walls for measuring NE uptake activity, chemical NE content, and noradrenergic nerve profiles.
NE Tracer Study
A modification13 of the NE tracer technique described by Rose et all' was used to measure NE uptake kinetics in vivo. After the dog was sedated with intravenous morphine (6 mg) and locally anesthetized, angiographic catheters were inserted into the coronary sinus and the ostium of the left coronary artery via an external jugular vein and a carotid artery, respectively.
A mixture of [1"I]albumin, [`4C]sucrose, and [3H]NE
was then injected into the coronary artery, and a timed, continuous sampling of coronary sinus blood (19 mL/ min) was begun and continued during the ensuing 60 seconds. The activity for each of the three tracers in the coronary sinus samples was divided by the total activity injected to arrive at a relative extraction fraction. The extraction fraction was then plotted against time for each tracer. Using the computerized algorithms developed by Rose et all' and modified for use on an IBM PC using Turbo Pascal, the rate constants for the bidirectional diffusion of sucrose across the capillary membrane, the bidirectional diffusion of NE across the capillary membrane, and the unidirectional transport of NE into the adrenergic nerves from the interstitium (K,) were calculated. 
Anatomic Studies of Ventricular Sympathetic Nerves
Glyoxylic acid-induced histofluorescence for catecholamines. Histofluorescence specific for catecholamines was done using a modification16 of the sucrose-potassium phosphate-glyoxylic acid (SPG) condensation method of de la Torre.17 Tissue blocks from fresh heart were rapidly frozen on dry ice and stored in liquid nitrogen. Blocks were mounted on a cryostat (-200C) for either longitudinal or cross section at thickness of 16 gm. Sections were picked up on glass slides, dipped in SPG solution, dried, heated under oil at 95WC for 2.5 minutes, coverslipped, and viewed under ultraviolet light using a Nikon fluorescence microscope equipped with epi-illumination accessories. All sections were photographed at the same magnification (x 50) using 35-mm slide film. The number of stained catecholamine profiles were counted in a 0.221-mm2 (0.003536 mm3) field; the results of five fields were summed to provide an average for each ventricle.
Immunocytochemistry for tyrosine hydroxylase. Ventricular muscle blocks were fixed for 24 (Fig 1) . However, unlike the chamber-specific reduction of NE uptake activity in RHF dogs, NE uptake activity was reduced in both right and left ventricles of the LHF dogs. NE uptake activity did not differ significantly in LHF between the two ventricles. In addition, the in vitro measurements of left ventricular NE uptake activity correlated significantly with the in vivo rate constant for NE uptake (r=.871, P<.001).
Plasma and Myocardial NE Levels in Heart Failure
Congestive heart failure was associated with increased plasma NE and reduced myocardial NE in both RHF and LHF models ( 
Effects of Chronic NE Infusion
Plasma NE was markedly elevated in dogs receiving NE infusion. At the final hemodynamic study, plasma NE was 4.59±0.49 ng/mL, which was 15 times that in the saline-infused animals (0.30±0.04 ng/mL, P< .0001). Table 4 shows that the two groups did not differ in body weight, nor did they differ in mean aortic pressure, left atrial pressure, left ventricular peak dP/dt, left ventricular dP/dt/P, or cardiac output. There was, however, a significant decrease in heart rate in the NE-infused animals. Table 5 shows that chronic NE infusion reduced the tissue SPG histofluorescence profiles in the left and right ventricles by 40%. These changes in NE-infused animals were associated with reduced tyrosine hydroxylase immunoreactive profiles and myocardial NE uptake activity. Kn was also lower in the NE-infused animals (0.289±0.054 s') than the saline-infused animals (0.956±0.203 s', P<.01). The chemical NE levels, however, did not differ significantly in the left ventricle between the NE (1154±182 ng/g, n=8) and saline (1565±122 ng/g, n=7, t=1.81, P=.094) groups.
Discussion
Congestive heart failure was produced in both models of experimental heart failure. This was evidenced by the low cardiac output, elevated right atrial pressure, ascites, and hepatomegaly. However, unlike RHF, in which left atrial pressure is reduced, rapid ventricular pacing produces a state of biventricular heart failure as manifested by elevated right and left atrial pressures and an increased lung weight. The present studies extend our prior findings in RHF that cardiac NE content and NE uptake activity are reduced in animals with LHF. A significant correlation existed between the NE uptake activity measured in vitro using the left ventricular tissue slices and the rate constant for the unidirectional NE uptake obtained in vivo from the NE tracer technique.
Our present studies further show that the noradrenergic nerve profiles as demonstrated by SPG-induced catecholaminergic histofluorescence and tyrosine hydroxylase immunocytochemistry are reduced in the failing ventricles. In addition, NE uptake-1 (mazindolbinding) site density8 and neuropeptide y18 are reduced in the failing myocardium. The NE uptake-1 site is a plasma membrane marker, whereas neuropeptide Y and NE are contained in different intraneuronal storage vesicles but are released together after sympathetic stimulation. 19 Since the NE uptake-1 site and neuropeptide Y are structurally and functionally distinct from the NE storage vesicles and tyrosine hydroxylase profiles, the noradrenergic nerve abnormalities in congestive heart failure cannot be explained by a defect in the NE synthesis, storage, or release processes alone. These changes most likely are caused by loss of adrenergic nerve terminals in the failing ventricle. However, the increase in cardiac sympathetic activity in heart failure20 could also contribute to the reduction of cardiac NE storage, particularly if the NE reuptake mechanism is impaired. Sympathetic denervation has been shown by electron microscopy in atrial myocardium obtained from humans with congestive heart failure.2' Furthermore, because tyrosine hydroxylase activity was not reduced in the stellate ganglia of the LHF dogs (unpublished data), the neuronal loss probably is caused by a local factor within the failing myocardium rather than by a descending degenerative process from the nerve bodies.
Although its filling pressure was not elevated, the left ventricle showed reduced contractile function in RHF. This was accompanied by reduced cardiac chemical NE content and SPG-induced histofluorescence profiles; these changes, however, were much smaller than those in the failing right heart of the same animals. Furthermore, cardiac NE store showed a greater proportional reduction (66%) than SPG-induced histofluorescence LV weight (g)
118±4 108±5
Liver (g)
696±46 614±23
Values are mean±SE. The number of experiments in each group is given in parentheses under the heading. NE indicates norepinephrine and bpm, beats per minute.
*P<.001 compared with saline-infused dogs.
directly or indirectly, in causing the loss of noradrenergic nerve terminals in heart failure. This is further supported by our pilot studies in dogs without tricuspid avulsion that NE uptake activity did not decrease after progressive pulmonary constriction, which produced right ventricular hypertrophy without elevated right atrial pressure. Prior studies have shown that cardiac neurotransmitter activity is altered in heart failure. Decrease in cardiac NE content has been amply demonstrated in humans18'23-26 and animals with congestive heart failure.1,2,27-30 However, changes in cardiac NE synthesis in heart failure have been limited to determinations of certain synthetic enzyme activities. Cardiac tyrosine hydroxylase activity decreased in human congestive heart failure.26 Similarly, tyrosine hydroxylase activity was reduced in the right ventricles of dogs with tricuspid avulsion and pulmonary occlusion for 2 to 8 weeks. 31 The left ventricle showed a relatively small reduction of tyrosine hydroxylase activity during this period. However, tyrosine hydroxylase activity could be reduced to a much lower level in the left ventricle in dogs with RHF for more than 2 years of duration. 32 On the other hand, dopamine 8-hydroxylase activity was reduced in the cardiomyopathic Syrian hamster. 33 We know of no published studies that applied the immunohistochemical technique to investigate cardiac innervation in our animal models of congestive heart failure. Nevertheless, a recent study by Wharton et al,34 using an immunohistochemical technique similar to ours did show a moderate number of tyrosine hydroxylase immunostained nerve fibers in the ventricular muscles in cardiac transplant recipient hearts. However, because neither the degree of heart failure was documented nor normal control hearts were included in that study, it cannot be stated whether the density of the tyrosine hydroxylase immunostained nerve fibers are reduced in the patients with end-stage cardiomyopathies.
As stated previously, an increase in cardiac sympathetic discharges and release of NE into the coronary sinus202425 have been used to explain myocardial NE depletion in heart failure. However, Spann et al,28 using an in vivo labeling technique, found the absolute levels of specific activity and the rates of disappearance of radiolabeled NE were identical in the left ventricles of normal guinea pigs and animals with heart failure produced by aortic constriction. They concluded that NE release was not increased in the failing heart. Other studiesll25 have shown that cardiac NE release is reduced in patients with heart failure. The discrepancies in the above studies may be related to differences in animal models, duration and degree of heart failure, or methods of measurement. Close examination of the state of the noradrenergic nerves in the failing heart may help to resolve these differences among various conditions. We have observed similar findings in two very different models of heart failure suggesting that localized abnormalities of the noradrenergic nerve terminals may have a pathophysiological role in the failing myocardium. These findings also suggest that the changes in noradrenergic nerve profiles cannot be explained by surgical implantation of pulmonary artery occluders or insertion of pacemakers. One possible scenario that seems to explain many of the findings discussed above may also help account for some of the discrepancies in the literature. With the induction of heart failure, cardiac noradrenergic activity increases reflexly to compensate for decreased cardiac output and arterial pressure. The increased cardiac filling pressure may enhance local NE release and predispose the failing ventricle to develop reduced neuronal NE reuptake via an unidentified local mechanism. The increased neuronal release and reduced reuptake of NE will then lead to a higher interstitial NE concentration and lower tissue NE content. An increased interstitial NE concentration was recently demonstrated in the pacing-induced failing left ventricle.13 If NE depletion is severe enough, SPG-induced histofluorescence will not be sensitive enough to visualize nerves. Under normal conditions, one would expect tyrosine hydroxylase activity to increase to keep up with increased demands for NE. However, in the present study, tyrosine hydroxylase stained profiles were actually decreased in the failing ventricle. These results suggest that the nerves themselves are damaged. As nerves become more damaged, particularly as they lose the capacity for NE synthesis, NE release would actually decrease. Finally, over a long time course, there may be repair or regrowth of nerves, further confusing the picture of damage. From the current study, the implications are that some process is damaging sympathetic nerves to the point at which they are not able to produce enough tyrosine hydroxylase to be visualized in the failing heart with elevated filling pressure.
In the present study, we have provided direct evidence that chronic NE infusion could lead to cardiac noradrenergic nerve abnormalities similar to those found in the failing myocardium. These findings suggest that excess NE plays a primary, pivotal role in the pathogenesis of cardiac noradrenergic nerve damage and that the elevated cardiac filling pressure is not essential for development of noradrenergic nerve abnormalities. However, these changes of noradrenergic nerve terminals occur at much higher plasma NE levels in the NE-infused animals than the LHF dogs. The increased wall tension imposed by the elevated cardiac filling pressure in congestive heart failure may be injurious and contributes to the noradrenergic nerve abnormalities by either causing local NE release or predisposing the cardiac noradrenergic nerves to the neurotoxic effect of NE in the heart.
Unlike that in congestive heart failure, the central sympathetic nervous system may be inhibited in NEinfused dogs. The decrease in heart rate in the NEinfused dogs, which also has been reported previously, 36 ,37 may be a manifestation of the centrally mediated cardiac noradrenergic nerve activity inhibition. However, inhibition of noradrenergic nerve activity would not explain the concomitant reductions of NE uptake activity, SPG catecholaminergic profiles, and tyrosine hydroxylase immunostained profiles observed in our NE-infused dogs.
Noradrenergic nerve damage has been shown to occur in saphenous veins after local infusions of NE. 38 The changes are similar to those produced by 6-hydroxydopamine.3940 Since chemical sympathectomy is prevented by desipramine or superoxide dismutase, the nerve damage produced by NE has been speculated to be caused by oxygen free radicals derived from NE with an action involving the neuronal uptake mechanism.38 Additional studies are warranted to determine the exact mechanisms by which excess NE causes cardiac denervation and whether desipramine or superoxide dismutase can be used to prevent cardiac denervation in heart failure.
